Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group
Author(s) -
Sumit Gupta,
Cindy Wang,
Elizabeth A. Raetz,
Reuven J. Schore,
Wanda L. Salzer,
Eric Larsen,
Kelly W. Maloney,
Len A. Mattano,
William L. Carroll,
Naomi J. Winick,
Stephen P. Hunger,
Mig L. Loh,
Meenakshi Devidas
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.03024
Subject(s) - medicine , discontinuation , asparaginase , hazard ratio , acute lymphocytic leukemia , lymphoblastic leukemia , chemotherapy , leukemia , surgery , pediatrics , oncology , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom